Fibrinogen Human Completed Phase 2 Trials for Coronary Artery Disease / Complications / Bleeding Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00968045Fibrinogen and Bleeding After Cardiac Surgery